Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
ELV stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Elevance Health, Inc. stock logo

Elevance Health, Inc.

ELV·NYSE

Last updated as of 2026-02-12 24:16 EST. Stock price information is sourced from TradingView and reflects real-time market prices.

Insights
Calculator
News

ELV stock price change

On the last trading day, ELV stock closed at 327.74 USD, with a price change of 0.64% for the day.
Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more

ELV key data

Previous close327.74 USD
Market cap72.33B USD
Volume237.90K
P/E ratio13.05
Dividend yield (TTM)2.10%
Dividend amount1.71 USD
Last ex-dividend dateDec 05, 2025
Last payment dateDec 19, 2025
EPS diluted (TTM)25.11 USD
Net income (FY)5.66B USD
Revenue (FY)199.13B USD
Next report dateApr 22, 2026
EPS estimate10.580 USD
Revenue estimate48.77B USD USD
Shares float220.06M
Beta (1Y)0.25
Tokenized stocks

Have you heard of tokenized stocks?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

Elevance Health, Inc. overview

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Sector
Health services
Industry
Managed Health Care
CEO
Gail Koziara Boudreaux
Headquarters
Indianapolis
Website
elevancehealth.com
Founded
1944
Employees (FY)
97.1K
Change (1Y)
−7.1K −6.81%
Revenue / Employee (1Y)
2.05M USD
Net income / Employee (1Y)
58.31K USD

ELV Pulse

Daily updates on ELV stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• ELV Stock Price 24h change: -0.57%. From 327.50 USD to 325.64 USD.
• The price decline was primarily driven by a downward revision of Q3 2026 EPS estimates by Zacks Research and lingering investor caution following the company's soft 2026 guidance, which anticipates medical cost pressures and a low single-digit decline in operating revenue.
• Technical analysis indicates a "Strong Sell" or bearish trend; ELV is currently trading below its 20-day ($329.40), 50-day ($334.66), and 200-day ($356.21) simple moving averages. While the RSI (14) at 45.43 is neutral, the MACD is signaling a sell, suggesting continued short-term downward momentum as the stock seeks a support floor.
• Equities research analysts at Zacks Research cut their Q3 2026 EPS estimates for Elevance Health to $5.41 per share, citing operational headwinds and a cautious full-year outlook.
• Elevance Health officially increased its quarterly dividend to $1.72 per share, signaling a commitment to shareholder returns despite a "reset year" characterized by Medicare and Medicaid margin pressures.
• Wealthfront Advisers LLC significantly increased its position in ELV by 122.5% during the most recent reporting period, reflecting institutional interest in the stock's long-term value despite recent volatility.
• The managed care sector faced a significant shock as the federal government proposed a near-flat 0.09% Medicare Advantage rate increase for 2027, far below the 4-6% analysts had anticipated, impacting projected profitability across the industry.
• CMS issued new data showing a massive surge in independent dispute resolution cases (1.2 million in the first half of 2025), with providers prevailing in 88% of cases and receiving payments 3-4 times higher than in-network rates, increasing cost burdens for insurers.
See more
about 13h ago
• ELV Stock Price 24h change: -0.50%. From 327.50 USD to 325.64 USD (as of Feb 9 close). Price slightly declined due to investor caution following a softer-than-expected 2026 margin outlook and recent analyst downgrades.
• From a technical perspective, the stock is in a "bearish phase with signs of bottoming": ELV is trading below its 50-day ($350.95) and 200-day ($344.93) moving averages, indicating a strong downward trend. However, RSI near 42 and Bollinger Band positions suggest the stock is reaching oversold territory, potentially finding support near its 52-week low.
• RBC Capital downgraded Elevance Health to "Sector Perform" with a $358 target, citing a weaker 2026 earnings guide and persistent medical cost pressures in government plans.
• Elevance Health officially raised its quarterly dividend to $1.72 per share (2.1% yield) and reaffirmed its focus on share repurchases and balance sheet strength over new acquisitions.
• The company reported Q4 2025 revenue of $49.3 billion and adjusted EPS of $3.33, beating estimates, but lowered 2026 EPS guidance to $25.50 due to Medicaid membership attrition and high utilization.
• President Trump signed a major federal funding bill on Feb 6 that includes expansive PBM reforms, targeting rebate transparency and "delinking" fees, which significantly impacts managed care revenue models.
• The managed care sector faced broad pressure after CMS proposed flat 2027 Medicare Advantage rates, triggering a sell-off across peers like UnitedHealth and Humana due to potential margin compression.
See more
about 1D ago

ELV stock price forecast

According to technical indicators for ELV stock, the price is likely to fluctuate within the range of 365.66–399.85 USD over the next week. Market analysts predict that the price of ELV stock will likely fluctuate within the range of 355.92–523.21 USD over the next months.

Based on 1-year price forecasts from 54 analysts, the highest estimate is 914.46 USD, while the lowest estimate is 229.13 USD.

For more information, please see the ELV stock price forecast Stock Price Forecast page.

Latest ELV stock news

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of Elevance Health, Inc.?

ELV is currently priced at 327.74 USD — its price has changed by 0.64% over the past 24 hours. You can track the stock price performance of Elevance Health, Inc. more closely on the price chart at the top of this page.

What is the stock ticker of Elevance Health, Inc.?

Depending on the exchange, the stock ticker may vary. For instance, on NYSE, Elevance Health, Inc. is traded under the ticker ELV.

What is the stock forecast of ELV?

We've gathered analysts' opinions on Elevance Health, Inc.'s future price. According to their forecasts, ELV has a maximum estimate of 3277.35 USD and a minimum estimate of 655.47 USD.

What is the market cap of Elevance Health, Inc.?

Elevance Health, Inc. has a market capitalization of 72.33B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
ELV